HLA-B and diffuse large B-cell lymphoma: HLA-B (rs2523607) locus has been associated with DLBCL risk, initially described in a GWAS study with 3857 cases/7766 controls from European population (OR = 1.32; 95% CI = 1.21–1.44; p = 2.40 × 10−10) and then reported in 1124 patients and 3596 controls from Asian population (OR = 3.05; 95% CI = 1.32–7.05; p = 9.0 × 10−3), though not reaching genome-wide significance [32,33] (Table 1).